Twitxy Saved

Leandro Slipczuk

Verified account This account is verified. Learn more

@CardioMDPhD

System Director, Non-Invasive Cardiology @montefioreNYC @einsteinmed @MonteHeart. Editor-in-Chief @PCVDJournal
New York, NY montefiore.org/body_mobile.cf… Joined June 2017
1.6K Following 2.6K Followers 1.8K Posts

Latest posts 5

Leandro Slipczuk Verified account @CardioMDPhD
Lp(a)HORIZON was negative. But what exactly did it disprove?

Not that Lp(a) is causal.
Not that we can lower it.
It challenged whether pharmacologic lowering reduces events.
The full data with component outcomes, precision, subgroup analyses, and timing will determine what comes next.

New viewpoint in @PCVDJournal

@AbdelazizMD1 @DLBHATTMD @ElsevierConnect

sciencedirect.com/science/articl…
3 replies 11 reposts 50 likes 5.3K views View on X
Leandro Slipczuk Verified account @CardioMDPhD
Happy to share our editorial, "Another Win for Lifestyle Medicine: Cardiac Rehabilitation–Based Therapy for ANOCA," published in JACC: Cardiovascular Interventions alongside the important SAMCRO randomized trial.

Despite the absence of obstructive coronary artery disease, patients with angina and no obstructive coronary arteries (ANOCA) often experience persistent symptoms, impaired quality of life, repeated testing, and uncertainty regarding their diagnosis. The challenge is no longer simply recognizing ANOCA but delivering effective, comprehensive treatment.

Congratulations to the investigators for advancing the field with high-quality randomized evidence, and to my co-authors Chip Lavie and Fabian Sanchis-Gomar for the opportunity to collaborate on this editorial.

Editorial: authors.elsevier.com/a/1nVvY6uPJw09…
Original research: sciencedirect.com/science/articl…

@CarlLavie31733 @MonteHeart @JACCJournals @ElsevierConnect